Percutaneous Thermal Ablation for Hepatocellular Carcinoma
Year: 2020
Type: article
Abstract: Percutaneous thermal ablation is a commonly used treatment for focal hepatocellular carcinoma (HCC), particularly effective for small and early-stage tumors (<3 cm in diameter). When executed expertly in appropriately selected patients, ablation may be curative with survival outcomes similar to surgical resection.[ 1 ] [ 2 ] [ 3 ] In the United States, heat-based modalities such as radiofrequency ablation (RFA) and microwave ablation (MWA) are favored due to the ability to quickly generate coagulation necrosis and help maintain hemostasis. Herein, we will review our recommended patient section parameters, preprocedural management, heat-based ablation techniques for commonly encountered scenarios, and postprocedural management. Publication History Article published online: 11 December 2020 © 2020. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
Authors: Jeffrey L. Weinstein, Muneeb Ahmed
Institutions: Beth Israel Deaconess Medical Center, Harvard University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3110862522